Page last updated: 2024-11-06

n(1)-acetylsulfamethoxazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID87725
MeSH IDM0075952

Synonyms (20)

Synonym
ro52928
n-(4-aminophenyl)sulfonyl-n-(5-methylisoxazol-3-yl)acetamide
acetamide, n-[(4-aminophenyl)sulfonyl]-n-(5-methyl-3-isoxazolyl)-
n(1)-acetylsulfamethoxazole
n-(4-aminophenyl)sulfonyl-n-(5-methyl-1,2-oxazol-3-yl)acetamide
n(1)-acetylsulphamethoxazole
acetamide, n-((4-aminophenyl)sulfonyl)-n-(5-methyl-3-isoxazolyl)-
n-((4-aminophenyl)sulphonyl)-n-(5-methylisoxazol-3-yl)acetamide
einecs 242-446-0
18607-98-2
acetamide,n-[(4-aminophenyl)sulfonyl]-n-(5-methyl-3-isoxazolyl)-
n1-acetylsulfamethoxazol
DTXSID70171852
n-[(4-aminophenyl)sulphonyl]-n-(5-methylisoxazol-3-yl)acetamide
n-[(4-aminophenyl)sulfonyl]-n-(5-methylisoxazol-3-yl)acetamide
n-((4-aminophenyl)sulfonyl)-n-(5-methylisoxazol-3-yl)acetamide
acetylsulfisomezole
EL4J65DX4B
n-[(4-aminophenyl)sulfonyl]-n-(5-methyl-3-isoxazolyl)acetamide
sulfamethoxazole-n1-acetyl

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" It also showed that this tendency was noticeable in dose elevation at fixed injection volume and became more significant for drugs with a smaller absorption rate and/or a larger elimination rate."( Studies on the absorption of practically water-insoluble drugs following injection VII: plasma concentration after different subcutaneous doses of a drug in aqueous suspension in rats.
Hirano, K; Yamada, H, 1983
)
0.27
" In addition, the absorption rate constants (j) of the mouse and rabbit were close to that of the rat when the drug concentration (C0) in the suspension and the injection volume (V0) were fixed."( Studies on the absorption of practically water-insoluble drugs following injection VIII: comparison of the subcutaneous absorption rates from aqueous suspensions in the mouse, rat, and rabbit.
Hirano, K; Yamada, H, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.12 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]